Biopharmaceutics and Pharmacokinetics Considerations

1. Routes of administrations and implication on drug bioavailability<br>2. Biopharmaceutics and Pharmacokinetics considerations in drug research<br>3. Bioavailability and bioequivalence research in Product Development<br>4. Pharmacokinetic characterization of drugs and new product designing<br>5. Pharmacokinetic Modulation with Particulate Drug Formulations<br>6. Dose, Dosage regimen and Dose adjustment<br>7. Implications of Bio-Nanotechnology in neuroscience, tissue engineering and cancer therapy<br>8. Physiologic pharmacokinetics models: Application and limitations<br>9. Chronopharmacokinetics in drug design<br>10. Drug toxicity and forensic pharmacokinetics<br>11. Recent advancements in Pharmacogenomics<br>12. Biocompatibility testing of biomaterials and biologicals<br>13. Metabolic kinetics<br>14. Animal handling and ethical considerations<br>15. Biopharmaceutic and pharmacokinetic aspects of controlled release systems<br>16. Degradation of biomaterials in biological environment<br>17. Safety and long-term toxicity evaluation of polymers used in Pharmaceutical Product Development: Regulatory considerations<br>18. Toxicity and toxicokinetic consideration in product development and drug research<br>19. Environmental and safety aspects of bio-nanotechnology<br>20. Toxicity considerations on repetitive accumulation of polymeric materials